ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 45 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458 | -16.1% | 210 | 0.0% | 0.00% | – |
| Q2 2023 | $546 | +116.7% | 210 | 0.0% | 0.00% | – |
| Q1 2023 | $252 | -26.3% | 210 | 0.0% | 0.00% | – |
| Q4 2022 | $342 | – | 210 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| OSAIC HOLDINGS, INC. | 9,712 | $21,173 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 33,485 | $72,997 | 0.00% |